Canopy CEO: We'll 'Disrupt the Heck' Out of Pharma
*By Carlo Versano*
At the end of a week that saw the nascent cannabis sector soar to record valuations (with enough [volatility](https://cheddar.com/videos/making-sense-of-tilrays-stock-chart) to make your head spin), at least one exec isn't getting high off his own supply.
Bruce Linton, CEO of Canopy Growth ($CGC), told Cheddar Friday that he is focused on using a recent $4 billion cash injection from Constellation Brands to accelerate his business operations as new markets open up for legal marijuana use.
The market for legal pot went from a handful of countries like Canada, where Canopy is based, to now over 30 globally, Linton said in an interview, and Constellation's stake "is the kind of rocket fuel we need."
As speculators send the stocks higher ー Canopy is up 100 percent since the August deal, while Tilray ($TLRY) is up 1,000 percent since its July IPO ー Linton is keeping his nose to the grindstone developing new uses for cannabis, illustrated by the 39 patents Canopy filed in the last year just for sleep-related cannabinoid products. He sees other uses as well, from anxiety to sports recovery, which begs the question: is Canopy a pharma company?
"We're going to have enough intellectual property and activity that it would be difficult for pharma companies...not to need to play with us," Linton said. "We're going to disrupt the heck out of them."
Speaking of disruption, Linton said he wasn't bothered by parallels with the dot-com bubble of the early 2000s. He said Canopy had more in common with a Google or Amazon ー established businesses with strong fundamentals ー than any of the internet stocks that were relegated to the tech boneyard after the bubble popped.
But for an industry like cannabis that is entirely dependent on regulation, there will always be a risk, Linton noted. For every country like Canada, which legalized medical marijuana in 2001 and will allow recreational use starting October 17, there's an Italy ー where medical marijuana is legal but heavily restricted ー or a Japan ー where it is strictly outlawed. Put another way, Canopy may have the best legal pot cultivation and distribution in the world, but its long-term success on a global scale may be capped by shifting regulatory and political climates.
Still, Linton sees the writing on the wall in places like South America, Australia, and the EU. As regulatory barriers come down, he said Canopy's strong production operations will lead the market.
"People can fight for who's going to be the second best," Linton said. "We're going to be the best and the largest and the most dominant on the planet over the next decade."
For full interview [click here](https://cheddar.com/videos/canopy-growth-blazing-a-trail).
Pax Labs, a leading electronic vaporizer company, plans to release its very first cannabis pod venture, of which different strands of cannabis will be available. COO Steven Jung spoke with Cheddar’s Chloe Aiello to talk about the release of the companies own line of 100 percent cannabis pods for use with its vaporizers. "I think this is the direction that most products are going," Jung noted. "If you look at the data, it would actually show you that most consumers are in fact looking for this kind of delivery mechanism in the product itself."
The gaming industry has seen multiple large scales deals this month alone, including Microsoft's megadeal for Activision Blizzard. And, seemingly in response, rival Sony, picked up Bungie for $3.6 billion, a studio once owned by both Microsoft and Activision. The sector is reportedly on track to spend $150 billion on mergers and acquisitions just this year alone, a record-breaking total, according to investment firm Drake Star Partners. Michael Metzger, a partner at the firm specializing in technology, media, and communications, joined Cheddar to discuss the flurry of deals in the gaming space and what might be behind the hot M&A activity.
Ari Redbord, head of legal and government affairs and TRM Labs, joins Cheddar News to discuss why Facebook is ditching its crypto project and what that means for the space.
Natalie Fertig, federal cannabis policy reporter at Politico Pro, joins Cheddar News to discuss a new YouGov poll that looks at how Americans feel about marijuana and politics.
After classic rocker Neil Young demanded removal of his music from Spotify over vaccine misinformation coming from The Joe Rogan Experience podcast, the platform made the decision to take down Young's songs and continue supporting Rogan with whom they have an exclusive contract. The move touched off a firestorm of controversy, leading to responses from both the streaming service and the podcasting host. Evan Nierman, CEO of Red Banyan Crisis PR, joined Cheddar to break down the latest on the fracas. "I think when [Spotify] initially said, we're not going to be commenting on that, that was a silly move because guess what? They did end up commenting about it, and nine times out of 10, when an organization says they're not going to be issuing a comment, they ultimately do," Nierman noted.
Tesla reported record profits for an electric fourth quarter, but investors still have plenty of questions. The EV giant will not be releasing any new vehicles this year and provided no updates on its Cybertruck. Cheddar News was joined by Ed Butowsky, Chapwood Investments Managing Partner to go over Tesla's quarter and analyze its concerns going forward.
Julius De Kempenaer, Senior Technical Analyst at Stockcharts.com, joined Cheddar News to break down what led to Apple's massive quarter, and what the future may hold for the tech giant as competition with Microsoft ramps up.
